EP2249647A4 - DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITY - Google Patents
DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITYInfo
- Publication number
- EP2249647A4 EP2249647A4 EP09708556A EP09708556A EP2249647A4 EP 2249647 A4 EP2249647 A4 EP 2249647A4 EP 09708556 A EP09708556 A EP 09708556A EP 09708556 A EP09708556 A EP 09708556A EP 2249647 A4 EP2249647 A4 EP 2249647A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pde4
- antagonistics
- muscarinic
- pharmacophores
- dual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2657208P | 2008-02-06 | 2008-02-06 | |
PCT/US2009/033130 WO2009100168A1 (en) | 2008-02-06 | 2009-02-05 | Dual pharmacophores - pde4-muscarinic antagonistics |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2249647A1 EP2249647A1 (en) | 2010-11-17 |
EP2249647A4 true EP2249647A4 (en) | 2012-07-18 |
Family
ID=40932308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09708556A Withdrawn EP2249647A4 (en) | 2008-02-06 | 2009-02-05 | DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITY |
Country Status (18)
Country | Link |
---|---|
US (1) | US8067408B2 (es) |
EP (1) | EP2249647A4 (es) |
JP (1) | JP2011511084A (es) |
KR (1) | KR20100120296A (es) |
CN (1) | CN101983010A (es) |
AR (1) | AR070564A1 (es) |
AU (1) | AU2009212410A1 (es) |
BR (1) | BRPI0908075A2 (es) |
CA (1) | CA2714419A1 (es) |
CL (1) | CL2009000248A1 (es) |
DO (1) | DOP2010000238A (es) |
EA (1) | EA201070927A1 (es) |
IL (1) | IL207351A0 (es) |
MX (1) | MX2010008692A (es) |
PE (1) | PE20091553A1 (es) |
TW (1) | TW200946526A (es) |
UY (1) | UY31635A1 (es) |
WO (1) | WO2009100168A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2552893B1 (en) | 2010-03-31 | 2014-10-29 | Actelion Pharmaceuticals Ltd. | Antibacterial isoquinolin-3-ylurea derivatives |
AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
EA201591220A1 (ru) | 2012-12-27 | 2016-01-29 | Дрексел Юниверсити | Новые противовирусные агенты против инфекции вирусом гепатита в |
KR20180011843A (ko) | 2015-06-11 | 2018-02-02 | 바실리어 파마슈티카 인터내셔널 리미티드 | 유출-펌프 억제제 및 이의 치료적 용도 |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
US20060252790A1 (en) * | 2002-12-23 | 2006-11-09 | Allen David G | Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
WO2008009735A1 (en) * | 2006-07-21 | 2008-01-24 | Glaxo Group Limited | Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925388A (en) * | 1971-08-05 | 1975-12-09 | Squibb & Sons Inc | 4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters |
US3856799A (en) * | 1971-08-05 | 1974-12-24 | Squibb & Sons Inc | Intermediates for production of amino derivatives of pyrazolopyridine carboxylic acids and esters |
US3833594A (en) * | 1971-08-05 | 1974-09-03 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxylic acids and esters |
BE787249A (fr) * | 1971-08-05 | 1973-02-05 | Squibb & Sons Inc | Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation |
CA1003419A (en) | 1971-11-23 | 1977-01-11 | Theodor Denzel | Process for the production of pyrazolo (3,4-b) pyridines |
US3840546A (en) * | 1972-11-15 | 1974-10-08 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxamides |
US3979399A (en) * | 1972-11-15 | 1976-09-07 | E. R. Squibb & Sons, Inc. | Amino derivatives of pyrazolopyridine carboxamides |
US4364948A (en) | 1981-09-28 | 1982-12-21 | Ici Americas Inc. | Pyrazolo[3,4-b]pyridine compounds |
US6326379B1 (en) | 1998-09-16 | 2001-12-04 | Bristol-Myers Squibb Co. | Fused pyridine inhibitors of cGMP phosphodiesterase |
US6670364B2 (en) * | 2001-01-31 | 2003-12-30 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
US6677365B2 (en) | 2001-04-03 | 2004-01-13 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
WO2003032989A1 (en) * | 2001-10-18 | 2003-04-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
US7544675B2 (en) | 2002-04-18 | 2009-06-09 | Ucb, S.A. | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
AR040779A1 (es) | 2002-08-06 | 2005-04-20 | Glaxo Group Ltd | Compuesto de tiazol anilina su uso para preparar una formulacion farmaceutica dicha formulacion recipiente que la contiene y dispositivo adaptado para la administracion intranasal de la formulacion |
PL375993A1 (en) | 2002-09-16 | 2005-12-12 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
US7232841B2 (en) | 2003-04-07 | 2007-06-19 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
PE20050327A1 (es) | 2003-07-17 | 2005-06-08 | Glaxo Group Ltd | Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina |
PE20050711A1 (es) | 2003-07-17 | 2005-09-10 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina |
TW200519108A (en) | 2003-07-17 | 2005-06-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
TW200811171A (en) | 2003-10-14 | 2008-03-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
OA13270A (en) | 2003-10-17 | 2007-01-31 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists. |
TW200524577A (en) | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
PE20050861A1 (es) | 2003-12-03 | 2005-12-10 | Glaxo Group Ltd | Derivados de sales ciclicas de amonio cuaternario como antagonistas del receptor muscarinico de acetilcolina |
AR046784A1 (es) | 2003-12-03 | 2005-12-21 | Glaxo Group Ltd | Compuesto de amina ciclica composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
US20070111995A1 (en) * | 2003-12-19 | 2007-05-17 | Allen David G | Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors |
TW200534855A (en) | 2004-01-13 | 2005-11-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
JP2007530451A (ja) | 2004-03-11 | 2007-11-01 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005087236A1 (en) | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
GB0405937D0 (en) * | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
WO2005090352A1 (en) | 2004-03-16 | 2005-09-29 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
GB0405933D0 (en) | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
JP2007529514A (ja) | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094251A2 (en) | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
WO2005095407A1 (en) | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
EP1725240A4 (en) | 2004-03-17 | 2009-03-25 | Glaxo Group Ltd | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR |
US20070238751A1 (en) | 2004-04-07 | 2007-10-11 | Laine Dramane I | Muscarinic Acetylcholine Receptor Antagonists |
TWI363759B (en) | 2004-04-27 | 2012-05-11 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
WO2005112644A2 (en) | 2004-05-13 | 2005-12-01 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
PE20060367A1 (es) | 2004-05-28 | 2006-04-28 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico |
EP1765339A4 (en) | 2004-06-30 | 2009-09-02 | Glaxo Group Ltd | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR |
US20070293531A1 (en) | 2004-08-05 | 2007-12-20 | Jakob Busch-Petersen | Muscarinic Acetycholine Receptor Antagonists |
WO2006017767A2 (en) | 2004-08-06 | 2006-02-16 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP1824483A4 (en) | 2004-10-29 | 2009-11-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
WO2007016639A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
EP1937230A4 (en) | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
US7767691B2 (en) | 2005-08-18 | 2010-08-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system |
US20070254913A1 (en) * | 2006-04-19 | 2007-11-01 | Dunn Robert F | Phosphodiesterase 4 inhibitors |
-
2009
- 2009-02-04 UY UY031635A patent/UY31635A1/es not_active Application Discontinuation
- 2009-02-04 AR ARP090100369A patent/AR070564A1/es not_active Application Discontinuation
- 2009-02-04 PE PE2009000166A patent/PE20091553A1/es not_active Application Discontinuation
- 2009-02-04 CL CL2009000248A patent/CL2009000248A1/es unknown
- 2009-02-04 TW TW098103480A patent/TW200946526A/zh unknown
- 2009-02-05 JP JP2010545974A patent/JP2011511084A/ja active Pending
- 2009-02-05 CA CA2714419A patent/CA2714419A1/en not_active Abandoned
- 2009-02-05 EA EA201070927A patent/EA201070927A1/ru unknown
- 2009-02-05 BR BRPI0908075-9A patent/BRPI0908075A2/pt not_active IP Right Cessation
- 2009-02-05 AU AU2009212410A patent/AU2009212410A1/en not_active Abandoned
- 2009-02-05 MX MX2010008692A patent/MX2010008692A/es unknown
- 2009-02-05 EP EP09708556A patent/EP2249647A4/en not_active Withdrawn
- 2009-02-05 KR KR1020107019715A patent/KR20100120296A/ko not_active Application Discontinuation
- 2009-02-05 CN CN2009801120277A patent/CN101983010A/zh active Pending
- 2009-02-05 WO PCT/US2009/033130 patent/WO2009100168A1/en active Application Filing
- 2009-02-05 US US12/365,934 patent/US8067408B2/en not_active Expired - Fee Related
-
2010
- 2010-08-02 IL IL207351A patent/IL207351A0/en unknown
- 2010-08-03 DO DO2010000238A patent/DOP2010000238A/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060252790A1 (en) * | 2002-12-23 | 2006-11-09 | Allen David G | Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
WO2008009735A1 (en) * | 2006-07-21 | 2008-01-24 | Glaxo Group Limited | Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
Non-Patent Citations (1)
Title |
---|
See also references of WO2009100168A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2249647A1 (en) | 2010-11-17 |
AU2009212410A1 (en) | 2009-08-13 |
US8067408B2 (en) | 2011-11-29 |
BRPI0908075A2 (pt) | 2015-08-25 |
MX2010008692A (es) | 2010-11-25 |
KR20100120296A (ko) | 2010-11-15 |
JP2011511084A (ja) | 2011-04-07 |
IL207351A0 (en) | 2010-12-30 |
CA2714419A1 (en) | 2009-08-13 |
CN101983010A (zh) | 2011-03-02 |
PE20091553A1 (es) | 2009-10-30 |
DOP2010000238A (es) | 2011-03-31 |
TW200946526A (en) | 2009-11-16 |
CL2009000248A1 (es) | 2009-09-11 |
UY31635A1 (es) | 2009-08-31 |
AR070564A1 (es) | 2010-04-21 |
EA201070927A1 (ru) | 2011-04-29 |
US20090197871A1 (en) | 2009-08-06 |
WO2009100168A1 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2280616A4 (en) | BODY FOR BABY | |
EP2257170A4 (en) | TÉTRAHYDROFUROPYRIDONES | |
PL2271613T3 (pl) | Hydroksymetylocykloheksyloaminy | |
EP2249646A4 (en) | PDE4 muscarinic Antagonist-DOPPELPHARMACOPHOREN | |
EP2285758A4 (en) | DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE | |
EP2313147A4 (en) | crimping | |
IL207352A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
ZA201006023B (en) | Thiazolyl-dihydro-indazoles | |
EP2233305A4 (en) | GRAPHIC PRINTER | |
GB0808924D0 (en) | Raingen | |
IL210407A0 (en) | Multi-bandage | |
EP2285375A4 (en) | SPIROAZAINDOLE | |
IL207351A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
IL207346A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
EP2249830A4 (en) | DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITY | |
GB0820503D0 (en) | Bulbmaster | |
GB0800161D0 (en) | Rota-board | |
GB0915525D0 (en) | Kat2 | |
GB0818939D0 (en) | Lubite | |
GB0810659D0 (en) | Permenforce | |
AU3972P (en) | Tobruk xTriticosecale | |
AU3935P (en) | DPV308 Dianella prunina | |
AU3977P (en) | PARV01 Myoporum parvifolium | |
AU4098P (en) | NPW2 Dianella tasmanica | |
GB0800296D0 (en) | Teletruck |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100903 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1150512 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120619 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 43/42 20060101AFI20120613BHEP Ipc: C07D 471/04 20060101ALI20120613BHEP Ipc: C07D 519/00 20060101ALI20120613BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GLAXO GROUP LIMITED |
|
17Q | First examination report despatched |
Effective date: 20130604 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20131015 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1150512 Country of ref document: HK |